PRICKLE2-AS1: A Potential Drug Target and Biomarker (G100652759)

Target Name: PRICKLE2-AS1

NCBI ID: G100652759

PRICKLE2-AS1

Other Name(s): RP11-129B22.1 | PRICKLE2 antisense RNA 1

PRICKLE2-AS1: A Potential Drug Target and Biomarker

Principal investigator: Dr. X

Institutions:

* University of X
* X Research Institute

Prickle2-AS1, also known as AS1-Prickle2, is a protein that is expressed in various tissues of the body, including the brain, pancreas, and heart. Its unique structure and expression pattern have made it an attractive target for researchers to investigate.

Recent studies have shown that Prickle2-AS1 is involved in several cellular processes that are important for various biological processes, including cell signaling, metabolism, and inflammation. Its expression has also been linked to several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

Drug Targeting

Prickle2-AS1 has been identified as a potential drug target due to its involvement in several cellular processes that are associated with disease. One of the primary targets of Prickle2-AS1 is the PI3K/Akt signaling pathway, which is a well-established pathway for cell signaling and metabolism.

The PI3K/Akt signaling pathway is involved in several cellular processes that are important for cancer growth, including cell division, angiogenesis, and immune evasion. Prickle2-AS1 has been shown to play a role in regulating the PI3K/Akt pathway in cancer cells.

In addition to its involvement in the PI3K/Akt pathway, Prickle2-AS1 has also been shown to be involved in the Met signaling pathway, which is involved in cell metabolism and energy homeostasis. The Met signaling pathway is also important for the development and progression of cancer.

Biomarker

Prickle2-AS1 has also been identified as a potential biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. The expression of Prickle2-AS1 has been shown to be elevated in various tissues of cancer cells, and its levels have been used as a biomarker for cancer diagnosis and treatment.

In addition to its potential as a biomarker, Prickle2-AS1 has also been shown to be involved in several diseases that are associated with inflammation. The expression of Prickle2-AS1 has been shown to be elevated in various tissues of individuals with autoimmune disorders, and its levels have been used as a biomarker for the diagnosis and treatment of these disorders.

Conclusion

Prickle2-AS1 is a protein that has been identified as a potential drug target due to its involvement in several cellular processes that are associated with disease. Its unique structure and expression pattern have made it an attractive target for researchers to investigate. Further studies are needed to fully understand the role of Prickle2-AS1 in disease and its potential as a drug target.

Protein Name: PRICKLE2 Antisense RNA 1

The "PRICKLE2-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PRICKLE2-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets